EN
RU
Diquafosol Tetrasodium (CAS: 211427-08-6) is a GMP-compliant, high-purity selective P2Y2 purinergic receptor agonist API. It promotes tear and mucin secretion to repair ocular surface damage, approved for dry eye disease treatment. It fully meets ICH, JP, USP and EP pharmacopoeial standards, ideal for ophthalmic eye drop formulation R&D and commercial manufacturing.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
211427-08-6GlobalEquipX is a professional B2B cross-border platform dedicated to the global pharmaceutical, biotech and laboratory research sectors. Our core product portfolio covers pharmaceutical stability & environmental test chambers, laboratory centrifuges, automated lab glassware washers, water purification systems, vacuum & fluid processing equipment, evaporation & concentration systems, cleanroom environment monitoring instruments, plus matched pharmaceutical raw materials and biological enzyme preparations. We also provide supporting accessories, technical support and after-sales services to meet overseas clients' one-stop procurement needs.
5908-99-6 Atropine Sulfate
1542321-58-3 Benzgalantamine Gluconate
73963-72-1 Cilostazol
1285572-51-1 Dotinurad
1229194-11-9 Edoxaban
Diquafosol Tetrasodium (CAS: 211427-08-6) is a GMP-compliant, high-purity selective P2Y2 purinergic receptor agonist API. It promotes tear and mucin secretion to repair ocular surface damage, approved for dry eye disease treatment. It fully meets ICH, JP, USP and EP pharmacopoeial standards, ideal for ophthalmic eye drop formulation R&D and commercial manufacturing.
Public Account
IPv6 network supported
Product categories
Technical Articles
